Alignment Healthcare (NASDAQ:ALHC) Announces Quarterly Earnings Results, Misses Estimates By $0.01 EPS

Alignment Healthcare (NASDAQ:ALHCGet Free Report) announced its quarterly earnings results on Thursday. The company reported ($0.25) EPS for the quarter, missing analysts’ consensus estimates of ($0.24) by ($0.01), Briefing.com reports. Alignment Healthcare had a negative return on equity of 84.43% and a negative net margin of 7.81%. The company had revenue of $628.60 million during the quarter, compared to analysts’ expectations of $599.75 million. During the same period last year, the firm earned ($0.20) earnings per share. Alignment Healthcare’s revenue for the quarter was up 43.1% on a year-over-year basis.

Alignment Healthcare Stock Performance

Alignment Healthcare stock opened at $6.63 on Friday. Alignment Healthcare has a fifty-two week low of $4.46 and a fifty-two week high of $9.20. The stock’s 50 day simple moving average is $5.12 and its two-hundred day simple moving average is $6.54. The company has a debt-to-equity ratio of 1.02, a quick ratio of 1.84 and a current ratio of 1.84. The stock has a market cap of $1.26 billion, a price-to-earnings ratio of -7.89 and a beta of 1.23.

Analysts Set New Price Targets

ALHC has been the topic of several recent analyst reports. Barclays initiated coverage on shares of Alignment Healthcare in a report on Wednesday, March 6th. They issued an “underweight” rating and a $4.50 target price on the stock. William Blair restated an “outperform” rating on shares of Alignment Healthcare in a research report on Wednesday, March 6th. Stifel Nicolaus lowered their price objective on shares of Alignment Healthcare from $11.00 to $9.00 and set a “buy” rating for the company in a research note on Tuesday, April 23rd. Stephens raised their target price on Alignment Healthcare from $6.00 to $7.00 and gave the stock an “equal weight” rating in a research note on Friday. Finally, UBS Group lowered their price target on Alignment Healthcare from $9.00 to $8.50 and set a “neutral” rating for the company in a research report on Wednesday, February 28th. One analyst has rated the stock with a sell rating, four have issued a hold rating, three have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $8.83.

Read Our Latest Report on Alignment Healthcare

Insider Transactions at Alignment Healthcare

In other news, CEO John E. Kao acquired 103,000 shares of the firm’s stock in a transaction on Thursday, March 14th. The stock was acquired at an average price of $4.82 per share, for a total transaction of $496,460.00. Following the completion of the acquisition, the chief executive officer now owns 2,745,253 shares in the company, valued at $13,232,119.46. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other Alignment Healthcare news, CEO John E. Kao acquired 103,000 shares of the company’s stock in a transaction that occurred on Thursday, March 14th. The shares were acquired at an average price of $4.82 per share, with a total value of $496,460.00. Following the completion of the purchase, the chief executive officer now directly owns 2,745,253 shares of the company’s stock, valued at approximately $13,232,119.46. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Dawn Christine Maroney sold 23,000 shares of the company’s stock in a transaction dated Friday, March 8th. The stock was sold at an average price of $5.44, for a total transaction of $125,120.00. Following the completion of the sale, the insider now owns 1,830,008 shares in the company, valued at approximately $9,955,243.52. The disclosure for this sale can be found here. In the last quarter, insiders sold 90,213 shares of company stock valued at $460,587. Corporate insiders own 6.30% of the company’s stock.

About Alignment Healthcare

(Get Free Report)

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.

Recommended Stories

Earnings History for Alignment Healthcare (NASDAQ:ALHC)

Receive News & Ratings for Alignment Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alignment Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.